BSCL2 Antikörper (AA 362-410)
Kurzübersicht für BSCL2 Antikörper (AA 362-410) (ABIN6745466)
Target
Alle BSCL2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 362-410
-
Spezifität
- Human BSCL2
-
Homologie
- Percent identity by BLAST analysis: Human, Mouse, Rat, Rabbit (100%) Horse (92%) Dog, Bovine (85%).
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide located between aa362-410 of human BSCL2 (Q96G97, NP_001116427). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Orangutan, Gibbon, Monkey, Galago, Mouse, Rat, Rabbit, Xenopus (100%), Bat, Horse (92%), Dog, Bovine (85%), Elephant (84%).
Type of Immunogen: Synthetic peptide
-
-
anti-Berardinelli-Seip Congenital Lipodystrophy 2 (Seipin) (BSCL2) (AA 263-354) antibody
BSCL2 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Berardinelli-Seip Congenital Lipodystrophy 2 (Seipin) (BSCL2) (AA 50-150) antibodyBSCL2 Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Berardinelli-Seip Congenital Lipodystrophy 2 (Seipin) (BSCL2) (AA 1-400) antibodyBSCL2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Berardinelli-Seip Congenital Lipodystrophy 2 (Seipin) (BSCL2) (AA 78-107), (N-Term) antibodyBSCL2 Reaktivität: Human, Maus WB, IHC (p) Wirt: Kaninchen Polyclonal RB19045 unconjugated
anti-Berardinelli-Seip Congenital Lipodystrophy 2 (Seipin) (BSCL2) (AA 259-357) antibodyBSCL2 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 1G4 unconjugated
anti-Berardinelli-Seip Congenital Lipodystrophy 2 (Seipin) (BSCL2) (AA 259-357) antibodyBSCL2 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Berardinelli-Seip Congenital Lipodystrophy 2 (Seipin) (BSCL2) (C-Term) antibodyBSCL2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Berardinelli-Seip Congenital Lipodystrophy 2 (Seipin) (BSCL2) (C-Term) antibodyBSCL2 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund, Kaninchen, Pferd WB Wirt: Kaninchen Polyclonal unconjugated
anti-Berardinelli-Seip Congenital Lipodystrophy 2 (Seipin) (BSCL2) (AA 85-115), (N-Term) antibodyBSCL2 Reaktivität: Human WB, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Distilled water
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- BSCL2 (Berardinelli-Seip Congenital Lipodystrophy 2 (Seipin) (BSCL2))
-
Andere Bezeichnung
- BSCL2
-
Hintergrund
-
Name/Gene ID: BSCL2
Synonyms: BSCL2, GNG3LG, SPG17, HMN5, Seipin -
Gen-ID
- 26580
-
NCBI Accession
- NP_001116427
-
UniProt
- Q96G97
Target
-
